Latest stories on ASMB
Texas Capital Securities initiates US Antimony stock with buy rating
Investing.com Analyst Ratings61 · neutralanalyst
Assembly Biosciences to Present at the H.C. Wainwright & Co. 28th Annual Global Investment Conference
Business Insider55 · neutralgeneral
Assembly Biosciences to Present at the H.C. Wainwright & Co. 28th Annual Global Investment Conference
GlobeNewswire55 · neutralgeneral
Assembly Biosciences Exercises U.S. Profit-Share Option for Herpes Program With Gilead
Morningstar63 · neutralm&a
Why is Assembly Biosciences stock surging today?
Investing.com Markets50 · neutralgeneral
Assembly Biosciences Exercises U.S. Profit-Share Option for Herpes Program With Gilead
MarketWatch63 · neutralm&a
Assembly Biosciences exercises profit share option with Gilead for HSV program
The Fly63 · neutralproduct/pr
Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program
Business Insider63 · neutralm&a
Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program
GlobeNewswire63 · neutralm&a
Assembly Biosciences price target raised to $53 from $45 at Mizuho
The Fly67 · bullishanalyst
UBS initiates Assembly Biosciences stock with buy rating on antiviral platform
Investing.com Analyst Ratings61 · neutralanalyst
Assembly Biosciences initiated with a Buy at UBS
The Fly61 · neutralanalyst
Mizuho lowers Assembly Biosciences stock price target to $45
Investing.com Analyst Ratings34 · bearishanalyst
Analysts like this humanoid supplier, even if the robots remain concepts — for now
CNBC58 · neutralanalyst
Analysts like this humanoid supplier, even if the robots remain concepts — for now
CNBC58 · neutralanalyst
H.C. Wainwright reiterates Assembly Biosciences stock rating at buy
Investing.com Analyst Ratings61 · neutralanalyst
Assembly Biosciences: Gilead Advancements For GS-1179 And ABI-6250 Is A Bullish Signal
Seeking Alpha63 · neutralproduct/pr
8-K/A - ASSEMBLY BIOSCIENCES, INC. (ASMB) files 8-K
SEC 8-K50 · neutralgeneral
Assembly Biosciences GAAP EPS of -$0.20 beats by $0.45, revenue of $13.37M beats by $6.92M
Seeking Alpha63 · neutralearnings
ASSEMBLY BIOSCIENCES, INC. (ASMB) files 8-K
SEC 8-K62 · neutralm&a
Assembly Biosciences Reports Second Quarter 2026 Financial Results and Recent Updates
Business Insider44 · neutralgeneral
Assembly Biosciences Reports Second Quarter 2026 Financial Results and Recent Updates
GlobeNewswire44 · neutralearnings
Assembly Biosciences: A Gilead-Backed Antiviral Option With More Embedded Leverage Than The Market Appreciates
Seeking Alpha63 · neutralproduct/pr